NeuroPace to Participate in Upcoming Healthcare Conferences in September
NeuroPace (Nasdaq: NPCE), a medical device company focused on epilepsy treatment, has announced its participation in two major healthcare conferences this September. The company will:
- Attend the Wells Fargo 2024 Healthcare Conference on September 4 in Boston, hosting one-on-one investor meetings
- Present at the Morgan Stanley 22nd Annual Global Healthcare Conference from September 4-6 in New York
At the Morgan Stanley conference, CEO Joel Becker and CFO Rebecca Kuhn will participate in a fireside chat on September 6 at 8:30am ET, which will be webcast live. They will also host one-on-one investor meetings. A replay of the fireside chat will be available on NeuroPace's Investor website.
NeuroPace (Nasdaq: NPCE), un'azienda di dispositivi medici focalizzata sul trattamento dell'epilessia, ha annunciato la sua partecipazione a due importanti conferenze sanitarie questo settembre. L'azienda:
- Parteciperà alla Wells Fargo 2024 Healthcare Conference il 4 settembre a Boston, ospitando incontri individuali con gli investitori
- Presenterà alla Morgan Stanley 22nd Annual Global Healthcare Conference dal 4 al 6 settembre a New York
Alla conferenza di Morgan Stanley, il CEO Joel Becker e il CFO Rebecca Kuhn parteciperanno a una chiacchierata informale il 6 settembre alle 8:30 ET, che sarà trasmessa in diretta. Inoltre, ospiteranno incontri individuali con gli investitori. Una registrazione della chiacchierata informale sarà disponibile sul sito web per gli investitori di NeuroPace.
NeuroPace (Nasdaq: NPCE), una empresa de dispositivos médicos enfocada en el tratamiento de la epilepsia, ha anunciado su participación en dos importantes conferencias de salud este septiembre. La empresa:
- Asistirá a la Wells Fargo 2024 Healthcare Conference el 4 de septiembre en Boston, organizando reuniones individuales con inversores
- Presentará en la Morgan Stanley 22nd Annual Global Healthcare Conference del 4 al 6 de septiembre en Nueva York
En la conferencia de Morgan Stanley, el CEO Joel Becker y la CFO Rebecca Kuhn participarán en una charla informal el 6 de septiembre a las 8:30 am ET, que será transmitida en vivo. También organizarán reuniones individuales con inversores. Una grabación de la charla informal estará disponible en el sitio web para inversores de NeuroPace.
NeuroPace (Nasdaq: NPCE)은 간질 치료에 중점을 둔 의료기기 회사로, 이번 9월 두 개의 주요 건강 관리 콘퍼런스에 참여한다고 발표했습니다. 회사는:
- 9월 4일 보스턴에서 열리는 Wells Fargo 2024 Healthcare Conference에 참석하여 개별 투자자 회의를 주최합니다.
- 9월 4일부터 6일까지 뉴욕에서 열리는 Morgan Stanley 22nd Annual Global Healthcare Conference에서 발표합니다.
Morgan Stanley 콘퍼런스에서는 CEO Joel Becker와 CFO Rebecca Kuhn이 9월 6일 오전 8시 30분 ET에 라이브 중계될 화로를 함께 진행하게 됩니다. 또한 그들은 개별 투자자 회의를 주최할 것입니다. 화로의 녹화는 NeuroPace의 투자자 웹사이트에서 확인할 수 있습니다.
NeuroPace (Nasdaq: NPCE), une entreprise de dispositifs médicaux spécialisée dans le traitement de l'épilepsie, a annoncé sa participation à deux grandes conférences de santé ce mois de septembre. L'entreprise va:
- Assister à la Wells Fargo 2024 Healthcare Conference le 4 septembre à Boston, en organisant des réunions individuelles avec des investisseurs
- Présenter lors de la Morgan Stanley 22nd Annual Global Healthcare Conference du 4 au 6 septembre à New York
Lors de la conférence de Morgan Stanley, le PDG Joel Becker et la CFO Rebecca Kuhn participeront à une discussion informelle le 6 septembre à 8h30 ET, qui sera diffusée en direct. Ils organiseront également des réunions individuelles avec des investisseurs. Un replay de la discussion informelle sera disponible sur le site web des investisseurs de NeuroPace.
NeuroPace (Nasdaq: NPCE), ein Unternehmen für medizinische Geräte, das sich auf die Behandlung von Epilepsie konzentriert, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im September bekannt gegeben. Das Unternehmen wird:
- Am Wells Fargo 2024 Healthcare Conference am 4. September in Boston teilnehmen und persönliche Investoren-Meetings ausrichten
- Vom 4. bis 6. September auf der Morgan Stanley 22nd Annual Global Healthcare Conference in New York präsentieren
Auf der Morgan Stanley-Konferenz werden CEO Joel Becker und CFO Rebecca Kuhn am 6. September um 8:30 Uhr ET an einem informellen Gespräch teilnehmen, das live übertragen wird. Sie werden auch persönliche Investoren-Meetings veranstalten. Eine Aufzeichnung des informellen Gesprächs wird auf der Investoren-Website von NeuroPace verfügbar sein.
- None.
- None.
MOUNTAIN VIEW, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in two healthcare conferences in September. NeuroPace management will host one-on-one meetings with investors at the Wells Fargo 2024 Healthcare Conference, on Wednesday, September 4 in Boston, MA.
NeuroPace will also present at the Morgan Stanley 22nd Annual Global Healthcare Conference, which takes place September 4-6, in New York, NY. Joel Becker, Chief Executive Officer, and Rebecca Kuhn, Chief Financial Officer, will participate in a fireside chat discussion on Friday, September 6 at 8:30am ET, and host one-on-one meetings with investors during the conference. The fireside chat will be accessible via a live webcast here and a replay will be available in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
What conferences will NeuroPace (NPCE) attend in September 2024?
When is NeuroPace's (NPCE) fireside chat at the Morgan Stanley conference?
Who will represent NeuroPace (NPCE) at the Morgan Stanley conference?
How can investors access NeuroPace's (NPCE) fireside chat at the Morgan Stanley conference?
